AMETEK Announces First Quarter Results


BERWYN, PA AMETEK, Inc. (NYSE: AME) recently announced its financial results for the first quarter ended March 31, 2022.

AMETEK’s first quarter 2022 sales were $1.46 billion, a 20% increase compared to the first quarter of 2021. Operating income increased 20% to $353.2 million and operating margins were 24.2% in the quarter with strong core margin expansion.

On a GAAP basis, first quarter earnings per diluted share were $1.17. Adjusted earnings in the quarter were $1.33 per diluted share, up 24% from the first quarter of 2021. Adjusted earnings adds back non-cash, after-tax, acquisition-related intangible amortization of $0.16 per diluted share. A reconciliation of reported GAAP results to adjusted results is included in the financial tables accompanying this release and on the AMETEK website.

“AMETEK had a strong start to the year. Our businesses navigated a difficult operating environment, delivering results exceeding our expectations,” said David A. Zapico, AMETEK Chairman and Chief Executive Officer. “Our focus on providing customers with differentiated technology solutions drove double-digit organic sales growth while AMETEK’s operational flexibility allowed us to generate excellent margin expansion and earnings growth. Additionally, end-demand remains strong with orders up 22% in the quarter resulting in a record $3.0 billion backlog.”

READ:  Vishay Intertechnology Introduces New High Precision Thin Film Wraparound Chip Resistor

Electronic Instruments Group (EIG)
EIG sales in the first quarter were $987.8 million, up 25% from the first quarter of 2021. EIG’s operating income in the quarter increased 18% to $244.8 million and operating income margins were 24.8%.

“EIG delivered fantastic results in the quarter,” noted Mr. Zapico. “Strong organic sales growth and contributions from recent acquisitions drove an impressive 25% increase in sales while AMETEK’s operational excellence initiatives drove excellent core margin expansion.”

Electromechanical Group (EMG)
First quarter EMG sales were $470.8 million, up 11% from the same quarter in 2021. EMG’s first quarter operating income was a record $128.2 million, up 22% versus the prior year, while operating income margins were a record 27.2%.

“EMG’s first quarter results were outstanding with broad based sales growth and exceptional operating performance resulting in robust margin expansion,” added Mr. Zapico.

READ:  IS&S Announces Significant Increase in Second Quarter Fiscal 2022 Revenues and Earnings

2022 Outlook  
“AMETEK’s performance in the first quarter reflects the strength of the AMETEK Growth Model. We remain well positioned to manage successfully in an uncertain environment including supply chain constraints, increased inflation, and the impacts of COVID-19 lockdowns in China. Despite these headwinds we continue to deliver strong and sustainable performance for all stakeholders,” continued Mr. Zapico.

“For 2022, we expect overall sales to be up high-single digits compared to 2021. Adjusted diluted earnings per share are now expected to be in the range of $5.34 to $5.44, an increase of 10% to 12% over the comparable basis for 2021. This is an increase from our previous guidance range of $5.30 to $5.42 per diluted share,” he added.

“We expect overall sales in the second quarter to be up low to mid-single digits versus the prior year. Adjusted earnings per diluted share are anticipated to be in the range of $1.27 to $1.30, up 10% to 13% compared to the second quarter of 2021,” concluded Mr. Zapico.

READ:  Zynerba Pharmaceuticals Reports First Quarter 2022 Financial Results, Operational Highlights

Thanks for visiting! MyChesCo brings reliable information and resources to Chester County, Pennsylvania. Please consider supporting us in our efforts. Your generous donation will help us continue this work and keep it free of charge. Show your support today by clicking here and becoming a patron.